Teva Pharmaceutical Industries TEVA
NYSE TEVA
$40.56 -0.29 (-0.71%)
As of: Oct 21, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Non-Current Deferred Tax Liability (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability came in at $289 million for Q2 2026, down 34.3% from $440 million a year earlier but up 5.9% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries' Non-Current Deferred Tax Liability was $296 million, down 38.7% from FY2024.

  • Non-Current Deferred Tax Liability carries a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
  • Going back by year, Non-Current Deferred Tax Liability was $483 million in FY2024 (-20.3%), $606 million in FY2023 (+10.6%), $548 million in FY2022 (-30.1%) and $784 million in FY2021 (-18.7%).
  • The five-year range for quarterly Non-Current Deferred Tax Liability is $273 million (Q1 2026) to $910 million (Q3 2021).
  • Year-over-year, Non-Current Deferred Tax Liability has declined for eight consecutive quarters, with an average decline of 25.1% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Deferred Tax Liability over five years came in Q4 2023 (growth of 10.6%), and the weakest in Q3 2022 (a decline of 44.7%).
  • Business Quant data shows TEVA's Non-Current Deferred Tax Liability at $273 million (Q1 2026), $296 million (Q4 2025) and $399 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Teva Pharmaceutical Industries 47.22 Bn 34.06 Bn 2.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 289.00 Mn
Mar 31, 2026 273.00 Mn
Dec 31, 2025 296.00 Mn
Sep 30, 2025 399.00 Mn
Jun 30, 2025 440.00 Mn
Mar 31, 2025 461.00 Mn
Dec 31, 2024 483.00 Mn
Sep 30, 2024 538.00 Mn
Jun 30, 2024 553.00 Mn
Mar 31, 2024 569.00 Mn
Dec 31, 2023 606.00 Mn
Sep 30, 2023 544.00 Mn
Jun 30, 2023 534.00 Mn
Mar 31, 2023 550.00 Mn
Dec 31, 2022 548.00 Mn
Sep 30, 2022 503.00 Mn
Jun 30, 2022 532.00 Mn
Mar 31, 2022 666.00 Mn
Dec 31, 2021 784.00 Mn
Sep 30, 2021 910.00 Mn
API Access

Teva Pharmaceutical Industries Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=TEVA&period=max&api_key=YOUR_API_KEY